A Phase 2 study of BL 001 in an obese
Latest Information Update: 11 Mar 2025
At a glance
- Drugs BL-001 (Primary)
- Indications Obesity
- Focus Therapeutic Use
Most Recent Events
- 11 Mar 2025 New trial record
- 04 Mar 2025 According to Bloom Science media release, company plans to initiate a Phase 2 study in an obese population in 2026